Cost-Effectiveness Analysis on3Chinese and Western Medicines in the Treatment of Senile Functional Constipation
HU Bao-rong
Abstract
HU Bao-rong
Abstract
OBJECTIVE:To evaluate the cost-effectiveness of3Chinese and western medicines in treating senile funcˉtional constipation.METHODS:186patients with senile functional constipation were randomly assigned to receive Forlax powder preparation for infusion,Liuweianxiao capsule and Buzhongyiqitang respectively,the therapeutic efficacies of the3groups were observed and the cost-effectiveness analysis were conducted12weeks after treatment.RESULTS:The cure rates for the3groups were77.6%,83.3%and85.5%,respectively;the costs for the3groups were963.52yuan,877.00yuan and850.12yuan,respectively;the ratio of cost to effectiveness were1241,1052and975,respectively;the incremental cost-effectiveness ratio of Group A and B were1435and1221as compared with Group C.CONCLUSION:Liuweianxiao capsule(Group B)was the preferred option for the treatment of senile functional constipation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To evaluate the cost-effectiveness of3Chinese and western medicines in treating senile funcˉtional constipation.METHODS:186patients with senile functional constipation were randomly assigned to receive Forlax powder preparation for infusion,Liuweianxiao capsule and Buzhongyiqitang respectively,the therapeutic efficacies of the3groups were observed and the cost-effectiveness analysis were conducted12weeks after treatment.RESULTS:The cure rates for the3groups were77.6%,83.3%and85.5%,respectively;the costs for the3groups were963.52yuan,877.00yuan and850.12yuan,respectively;the ratio of cost to effectiveness were1241,1052and975,respectively;the incremental cost-effectiveness ratio of Group A and B were1435and1221as compared with Group C.CONCLUSION:Liuweianxiao capsule(Group B)was the preferred option for the treatment of senile functional constipation.
Key concepts: Functional constipation, Medicine, Constipation, Capsule, Cost effectiveness, Cost-effectiveness analysis, Internal medicine, Cost analysis